Skip to main content
. 2021 Apr;62(4):561–567. doi: 10.2967/jnumed.120.249144

TABLE 3.

Total Distribution Volumes Derived with 1TC Model for 18F-SynVesT-1 and 11C-UCB-J Under Baseline and Levetiracetam Blocking Conditions

18F-SynVesT-1 (n = 4)
11C-UCB-J (n = 4)
Region Baseline Blocking Baseline Blocking
Putamen 18.7 (18%) 5.1 (14%) 20.5 (14%) 7.2 (10%)
Insular cortex 18.4 (21%) 4.9 (13%) 19.6 (15%) 6.9 (11%)
Temporal cortex 18.8 (20%) 4.6 (8%) 20.4 (15%) 6.8 (7%)
Parietal cortex 18.1 (21%) 4.3 (6%) 20.1 (15%) 6.6 (7%)
Amygdala 17.4 (13%) 4.7 (12%) 19.1 (13%) 7.0 (13%)
Occipital cortex 17.7 (24%) 4.2 (6%) 19.5 (20%) 6.3 (4%)
Anterior cingulate cortex 17.6 (21%) 4.8 (16%) 19.0 (20%) 7.0 (15%)
Frontal cortex 17.1 (18%) 4.3 (8%) 18.8 (12%) 6.4 (8%)
Caudate nucleus 15.9 (15%) 4.3 (12%) 17.6 (14%) 6.3 (12%)
Posterior cingulate cortex 15.9 (32%) 4.0 (9%) 16.9 (28%) 5.9 (19%)
Thalamus 13.3 (14%) 4.0 (13%) 14.5 (12%) 5.7 (6%)
Cerebellum 13.0 (17%) 3.6 (12%) 13.7 (13%) 5.2 (5%)
Hippocampus 13.2 (13%) 3.8 (11%) 14.1 (10%) 5.5 (10%)
Globus pallidus 11.9 (27%) 4.2 (14%) 12.5 (18%) 5.6 (6%)
CS 3.6 (13%) 2.4 (6%) 4.5 (10%) 3.4 (4%)

Data in parentheses represent %COV (percentage coefficient of variation [intersubject variability]).